Invention Grant
- Patent Title: Diacylglycerol kinase modulating compounds
-
Application No.: US17845534Application Date: 2022-06-21
-
Publication No.: US11976072B2Publication Date: 2024-05-07
- Inventor: Julian A. Codelli , Michael Graupe , Juan A. Guerrero , Stephen D. Holmbo , Tetsuya Kobayashi , Yasamin Moazami , Leena B. Patel , Heath A. Weaver , Jie Xu , Suet C. Yeung , QingMing Zhu
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61P31/18 ; A61P31/20 ; A61P35/00 ; A61P35/04 ; C07D519/00
Abstract:
The present disclosure provides diacylglycerol kinase modulating compounds, and pharmaceutical compositions thereof, for treating cancer, including solid tumors, and viral infections, such as HIV or hepatitis B virus infection. The compounds can be used alone or in combination with other agents.
Public/Granted literature
- US20230060354A1 DIACYLGLYERCOL KINASE MODULATING COMPOUNDS Public/Granted day:2023-03-02
Information query
